All Blogs

Apr 15, 2020

The Novel Coronavirus since its outbreak in Wuhan China in November-2019 has infected around 1,848,439 people with 117,217 confirmed deaths in 213 countries, till date.  Countries around the world are working tirelessly to tackle the current situation. Local Governments in order to reduce the pace of corona...

Apr 14, 2020

Eli Lilly has announced to begin clinical trials of rheumatoid arthritis drug Olumiant to treat COVID-19 patients.  The company plans to explore the anti-inflammatory responses that were witnessed in rheumatoid arthritis patients, and how the drug – Olumiant – an oral JAK1/JAK2 inhibitor – might help in cur...

Apr 13, 2020

Amid the political debate, the US NIH has last week begun the clinical trials of the malarial drug hydroxychloroquine to test its efficacy and safety in patients with COVID-19. What is hydroxychloroquine?  Hydroxychloroquine (HCQ) (aka hydroxychloroquine sulfate), is a drug available in the market to tre...

Apr 10, 2020

DelveInsight estimates by 2030, the Car-T cell therapy market in Acute lymphoblastic leukaemia would approximate to USD 1,315.7 million in the 6MM (U.S. and EU5 including UK, Germany, Italy, France and Spain), emerging as a multi-billion-dollar industry. Acute lymphocytic leukemia (ALL) is a tumor that afflic...

Apr 09, 2020

AstraZeneca aims for summer start for COVID-19 antibody trial AstraZeneca has made its multipronged approach to the development of antibodies against the pandemic SARS-CoV-2 virus. The giant is utilizing its discovery capabilities and assisting in assessing the candidates who were identified in China and the U.S...

Apr 08, 2020

The novel coronavirus (COVID-19) within a span of five months, has infected around 1 million people, resulting in deaths of 50,000 people in over 180 countries around the world till date.  The major issue right now is containing its rapid transmission and effective treatment option. Apart from these issues,...

Apr 07, 2020

World Health Day Today, 7 April, is World Health Day. While the world is waging war against COVID-19, let us take a moment to be grateful to the emergency stuff- Doctors, Heath workers, Nurses who are taking care of the patients all day and night during this Coronavirus pandemic crisis.  Everyone is mainta...

Apr 07, 2020

Immunomedics discontinues its trial early – hopes for accelerated approval of Sacituzumab govitecan for mTNBC Immunomedics- a New Jersey-based pharmaceutical company has announced to freeze its Phase III confirmatory ASCENT clinical trial of sacituzumab govitecan aimed at treating metastatic triple-negative brea...

Apr 06, 2020

Warm Autoimmune Hemolytic Anemia market is anticipated to increase with a CAGR of 15.9% in the 7MM by 2030, estimates DelveInsight. In 2017, as per the estimates by DelveInsight, Warm Autoimmune Haemolytic Anemia had affected 82,045 people approximately in the 7MM. For a disease being tagged - rare, WAIHA affect...

Apr 03, 2020

As per DelveInsight’s Warm Autoimmune Hemolytic anemia Epidemiology forecast and analysis, WAIHA prevalence in the 7MM was estimated to be around 82,045 cases. Autoimmune hemolytic anemia (AIHA) – a rare acquired autoimmune disease – is a consequence of dysfunction in the immune system, as a consequence of which...